Trial ID: | L1203 |
Source ID: | NCT00297219
|
Associated Drug: |
Low Dialysate Calcium
|
Title: |
Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
|
Acronym: |
|
Status: |
COMPLETED
|
Study Results: |
NO
|
Results: |
|
Conditions: |
End-Stage Renal Disease|Hemodialysis
|
Interventions: |
DRUG: Low dialysate calcium|DRUG: high dialysate calcium
|
Outcome Measures: |
Primary: Progression of coronary artery calcification scores, eighteen months|Changes in bone histomorphometry analysis, eighteen months|Changes in bone mineral density, eighteen months | Secondary: Changes in intact PTH levels, eighteen months|effects of dialysate with or without glucose (e.g intradialytic hypoglycemia and hypotension, arrythmia-by Holter ECG- and changes in HbA1c, insulin), eighteen months
|
Sponsor/Collaborators: |
Sponsor: Ege University | Collaborators: University of Kentucky|Fresenius Medical Care North America
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
|
Enrollment: |
457
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2005-11
|
Completion Date: |
2008-07
|
Results First Posted: |
|
Last Update Posted: |
2009-08-04
|
Locations: |
University of Kentucky Medical Center, Lexington, Kentucky, 40536-0084, United States|FMC Clinics, Bornova, Izmir, Turkey|Ege University School of Medicine, Bornova-Izmir, 35100, Turkey
|
URL: |
https://clinicaltrials.gov/show/NCT00297219
|